Having a medical team available to answer questions can help you feel more confident, more supported, and better prepared to stay on track
Scientific References Long R3 insulin-like growth factor-1 (IGF-1) stimulates muscle cell hypertrophy Pharmacokinetics and tissue distribution of IGF-1 LR3 in preclinical models Long R3 insulin-like growth factor I (IGF-I) stimulates protein synthesis in muscle cells IGF-1 LR3: a potent analog with reduced binding to IGF-binding proteins
Allowing for "quantity limit exceptions" does not minimize the problematic nature of this
Through this study, we aim to identify specific subpopulations where these medications may be safe to use. For more information: Hui Shao , M D, PhD , can be reached at [email protected].
10.1038/embor.2011.65 EMBO Rep
While the clinical presentation of THMD5 varies, affected individuals often experience episodic ataxia, dystonia, and lactic acidosis (123)